Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/wiley/regulatory-t-cells-a-review-of-manufacturing-and-clinical-utility-qrt4CVd0Fp
References (47)
-
A. Theil, S. Tuve, U. Oelschlägel, A. Maiwald, D. Döhler, Dennis Oßmann, Anja Zenkel, C. Wilhelm, J. Middeke, N. Shayegi, K. Trautmann-Grill, M. Bonin, U. Platzbecker, G. Ehninger, E. Bonifacio, M. Bornhäuser (2015)
Adoptive transfer of allogeneic regulatory T cells into patients with chronic graft-versus-host disease.Cytotherapy, 17 4
-
S. Sakaguchi, Tomoyuki Yamaguchi, T. Nomura, M. Ono (2008)
Regulatory T Cells and Immune ToleranceCell, 133
-
C. Brunstein, Jeffrey Miller, Q. Cao, D. McKenna, K. Hippen, J. Curtsinger, T. Defor, B. Levine, C. June, P. Rubinstein, P. Mcglave, B. Blazar, J. Wagner (2011)
Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics.Blood, 117 3
-
S. Dong, Kamir Hiam-Galvez, C. Mowery, K. Herold, S. Gitelman, Jonathan Esensten, Weihong Liu, A. Lares, Ashley Leinbach, Michael Lee, Vinhkhang Nguyen, Stanley Tamaki, W. Tamaki, Courtney Tamaki, Morvarid Mehdizadeh, A. Putnam, M. Spitzer, Chun Ye, Q. Tang, J. Bluestone (2021)
The effect of low-dose IL-2 and Treg adoptive cell therapy in patients with type 1 diabetesJCI Insight, 6
-
F. Noyan, Katharina Zimmermann, M. Hardtke‐Wolenski, A. Knoefel, E. Schulde, R. Geffers, Michael Hust, J. Huehn, Melanie Galla, Michael Morgan, A. Jokuszies, Michael Manns, E. Jaeckel (2017)
Prevention of Allograft Rejection by Use of Regulatory T Cells With an MHC‐Specific Chimeric Antigen ReceptorAmerican Journal of Transplantation, 17
-
Caroline Raffin, Linda Vo, J. Bluestone (2019)
Treg cell-based therapies: challenges and perspectivesNature Reviews Immunology, 20
-
S. Josefowicz, Li-Fan Lu, A. Rudensky (2012)
Regulatory T cells: mechanisms of differentiation and function.Annual review of immunology, 30
-
K. Chwojnicki, D. Iwaszkiewicz-Grześ, Anna Jankowska, M. Zieliński, Paweł Łowiec, Mateusz Gliwiński, Małgorzata Grzywińska, K. Kowalczyk, Aleksandra Konarzewska, P. Glasner, Justyna Sakowska, J. Kulczycka, Anna Jaźwińska-Curyłło, M. Kubach, B. Karaszewski, W. Nyka, E. Szurowska, P. Trzonkowski (2021)
Administration of CD4+CD25highCD127−FoxP3+ Regulatory T Cells for Relapsing-Remitting Multiple Sclerosis: A Phase 1 StudyBioDrugs, 35
-
J. Bluestone, Q. Tang (2018)
Treg cells—the next frontier of cell therapyScience, 362
-
J. Fontenot, M. Gavin, A. Rudensky (2003)
Foxp3 programs the development and function of CD4+CD25+ regulatory T cellsNature Immunology, 4
-
C. Brunstein, Jeffrey Miller, D. McKenna, K. Hippen, T. Defor, D. Sumstad, J. Curtsinger, M. Verneris, M. MacMillan, B. Levine, J. Riley, C. June, C. Le, D. Weisdorf, P. Mcglave, B. Blazar, J. Wagner (2016)
Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect.Blood, 127 8
-
A. Sánchez‐Fueyo, Gavin Whitehouse, Nathali Grageda, M. Cramp, T. Lim, M. Romano, Sarah Thirkell, K. Lowe, L. Fry, Julie Heward, A. Kerr, Jakia Ali, C. Fisher, Gillian Lewis, A. Hope, E. Kodela, M. Lyne, F. Farzaneh, S. Kordasti, I. Rebollo-Mesa, Juan Lozano, N. Safinia, R. Lechler, M. Martínez‐Llordella, G. Lombardi (2019)
Applicability, safety, and biological activity of regulatory T cell therapy in liver transplantationAmerican Journal of Transplantation, 20
-
R. Pahwa, Shashidhar Jaggaiahgari, S. Pahwa, L. Inverardi, A. Tzakis, C. Ricordi (2010)
Isolation and expansion of human natural T regulatory cells for cellular therapy.Journal of immunological methods, 363 1
-
Michel Tenspolde, Katharina Zimmermann, Leonie Weber, M. Hapke, M. Lieber, Janine Dywicki, A. Frenzel, M. Hust, Melanie Galla, L. Buitrago‐Molina, M. Manns, E. Jaeckel, M. Hardtke‐Wolenski (2019)
Regulatory T cells engineered with a novel insulin-specific chimeric antigen receptor as a candidate immunotherapy for type 1 diabetes.Journal of autoimmunity
-
Leonardo Ferreira, Y. Muller, J. Bluestone, Q. Tang (2019)
Next-generation regulatory T cell therapyNature Reviews Drug Discovery, 18
-
B. Sawitzki, P. Harden, P. Reinke, A. Moreau, James Hutchinson, D. Game, Q. Tang, E. Guinan, M. Battaglia, W. Burlingham, I. Roberts, M. Streitz, R. Josien, C. Böger, C. Scottà, J. Markmann, J. Hester, K. Juerchott, C. Braudeau, B. James, L. Contreras-Ruiz, J. Net, T. Bergler, R. Caldara, W. Petchey, M. Edinger, N. Dupas, Michael Kapinsky, I. Mutzbauer, N. Otto, R. Öllinger, M. Hernandez-Fuentes, F. Issa, N. Ahrens, Christoph Meyenberg, Sandra Karitzky, U. Kunzendorf, S. Knechtle, J. Grinyo, P. Morris, L. Brent, A. Bushell, L. Turka, J. Bluestone, R. Lechler, H. Schlitt, M. Cuturi, S. Schlickeiser, P. Friend, Tewfik Miloud, A. Scheffold, A. Secchi, K. Crisalli, Sang-Mo Kang, R. Hilton, B. Banas, G. Blancho, H. Volk, G. Lombardi, K. Wood, E. Geissler (2020)
Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trialsThe Lancet, 395
-
J. Riley, C. June, B. Blazar (2009)
Human T regulatory cell therapy: take a billion or so and call me in the morning.Immunity, 30 5
-
S Hori, T Nomura, S Sakaguchi (2003)
Control of regulatory T cell development by the transcription factor Foxp3, 299
-
M. Dominguez-Villar, D. Hafler (2018)
Regulatory T cells in autoimmune diseaseNature Immunology, 19
-
K. MacDonald, Romy Hoeppli, Qing Huang, Jana Gillies, D. Luciani, P. Orban, R. Broady, M. Levings (2016)
Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor.The Journal of clinical investigation, 126 4
-
V. Trouet, Jan Esper, Nicholas Graham, Andy Baker, J. Scourse, David, C. Frank (2002)
Supporting Online Material -
Dominic Boardman, Dominic Boardman, C. Philippeos, G. Fruhwirth, Mohammad Ibrahim, Mohammad Ibrahim, R. Hannen, D. Cooper, F. Marelli-Berg, F. Watt, Fiona Watt, R. Lechler, R. Lechler, J. Maher, J. Maher, J. Maher, L. Smyth, L. Smyth, G. Lombardi, G. Lombardi (2017)
Expression of a Chimeric Antigen Receptor Specific for Donor HLA Class I Enhances the Potency of Human Regulatory T Cells in Preventing Human Skin Transplant RejectionAmerican Journal of Transplantation, 17
-
N. Zwang, J. Leventhal (2017)
Cell Therapy in Kidney Transplantation: Focus on Regulatory T Cells.Journal of the American Society of Nephrology : JASN, 28 7
-
I. Dijke, Romy Hoeppli, T. Ellis, J. Pearcey, Qing Huang, Alicia McMurchy, K. Boer, A. Peeters, G. Aubert, I. Larsen, David Ross, I. Rebeyka, Andrew Campbell, C. Baan, M. Levings, Lori West (2016)
Discarded Human Thymus Is a Novel Source of Stable and Long‐Lived Therapeutic Regulatory T CellsAmerican Journal of Transplantation, 16
-
M. Itoh, Takeshi Takahashi, N. Sakaguchi, Y. Kuniyasu, J. Shimizu, F. Otsuka, S. Sakaguchi (1999)
Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance.Journal of immunology, 162 9
-
K. MacDonald, S. Ivison, K. Hippen, Romy Hoeppli, Michael Hall, Grace Zheng, I. Dijke, Mohammed Aklabi, Darren Freed, I. Rebeyka, Sanjiv Gandhi, Lori West, James Piret, Bruce Blazar, M. Levings (2019)
Cryopreservation timing is a critical process parameter in a thymic regulatory T-cell therapy manufacturing protocol.Cytotherapy
-
B. Blazar, K. Macdonald, G. Hill (2018)
Immune regulatory cell infusion for graft-versus-host disease prevention and therapy.Blood, 131 24
-
(2022)
Regulatory T cells: A review of manufacturing and clinical utility -
N. Safinia, T. Vaikunthanathan, H. Fraser, Sarah Thirkell, K. Lowe, L. Blackmore, Gavin Whitehouse, M. Martínez‐Llordella, W. Jassem, A. Sánchez‐Fueyo, R. Lechler, G. Lombardi (2016)
Successful expansion of functional and stable regulatory T cells for immunotherapy in liver transplantationOncotarget, 7
-
E. Husebye, Mark Anderson, O. Kämpe (2018)
Autoimmune Polyendocrine Syndromes.The New England journal of medicine, 378 12
-
E. Elinav, Nitzan Adam, T. Waks, Z. Eshhar (2009)
Amelioration of colitis by genetically engineered murine regulatory T cells redirected by antigen-specific chimeric receptor.Gastroenterology, 136 5
-
M. MacMillan, K. Hippen, D. McKenna, D. Kadidlo, D. Sumstad, T. Defor, C. Brunstein, S. Holtan, Jeffrey Miller, E. Warlick, D. Weisdorf, J. Wagner, B. Blazar (2021)
First-in-human phase 1 trial of induced regulatory T cells for graft-versus-host disease prophylaxis in HLA-matched siblings.Blood advances, 5 5
-
J. Mathew, Jessica H.-Voss, A. Lefever, I. Konieczna, Cheryl Stratton, Jie He, Xuemei Huang, L. Gallon, A. Skaro, M. Ansari, J. Leventhal (2018)
A Phase I Clinical Trial with Ex Vivo Expanded Recipient Regulatory T cells in Living Donor Kidney TransplantsScientific Reports, 8
-
N. Marek-Trzonkowska, M. Myśliwiec, D. Iwaszkiewicz-Grześ, Mateusz Gliwiński, I. Derkowska, M. Żalińska, M. Zieliński, Marcelina Grabowska, H. Zielińska, K. Piekarska, Anna Jaźwińska-Curyłło, R. Owczuk, A. Szadkowska, K. Wyka, P. Witkowski, W. Młynarski, P. Jarosz-Chobot, A. Bossowski, J. Siebert, P. Trzonkowski (2016)
Factors affecting long-term efficacy of T regulatory cell-based therapy in type 1 diabetesJournal of Translational Medicine, 14
-
J. Kellner, E. Delemarre, E. Yvon, S. Nierkens, J. Boelens, I. Mcniece, A. Olson, Y. Nieto, S. Ciurea, U. Popat, Saira Ahmed, R. Champlin, Jennifer Ramos, M. Nishimoto, Hongbing Ma, Zeng Ke, P. Thall, J. Khoury, R. Negrin, B. Andersson, S. Parmar (2018)
Third party, umbilical cord blood derived regulatory T-cells for prevention of graft versus host disease in allogeneic hematopoietic stem cell transplantation: feasibility, safety and immune reconstitutionOncotarget, 9
-
Weihong Liu, A. Putnam, Xu-yu Zhou, G. Szot, Michael Lee, Shirley Zhu, P. Gottlieb, P. Kapranov, T. Gingeras, Barbara Groth, C. Clayberger, David Soper, S. Ziegler, J. Bluestone (2006)
CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cellsThe Journal of Experimental Medicine, 203
-
Hori S (2003)
1057Science, 299
-
A. Roemhild, N. Otto, Guido Moll, M. Abou-el-Enein, Daniel Kaiser, G. Bold, T. Schachtner, Mira Choi, R. Oellinger, S. Landwehr-Kenzel, K. Juerchott, B. Sawitzki, Cordula Giesler, A. Sefrin, Carola Beier, D. Wagner, S. Schlickeiser, M. Streitz, Michael Schmueck-Henneresse, L. Amini, U. Stervbo, N. Babel, H. Volk, P. Reinke (2020)
Regulatory T cells for minimising immune suppression in kidney transplantation: phase I/IIa clinical trialThe BMJ, 371
-
R. Zeiser, B. Blazar (2017)
Acute Graft-versus-Host Disease - Biologic Process, Prevention, and Therapy.The New England journal of medicine, 377 22
-
P. Trzonkowski, M. Bieniaszewska, Jolanta Juścińska, A. Dobyszuk, A. Krzystyniak, Natalia Marek, J. Myśliwska, A. Hellmann (2009)
First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127- T regulatory cells.Clinical immunology, 133 1
-
N. Marek-Trzonkowska, M. Myśliwiec, A. Dobyszuk, Marcelina Grabowska, I. Techmańska, Jolanta Juścińska, M. Wujtewicz, P. Witkowski, W. Młynarski, A. Balcerska, J. Myśliwska, P. Trzonkowski (2012)
Administration of CD4+CD25highCD127− Regulatory T Cells Preserves β-Cell Function in Type 1 Diabetes in ChildrenDiabetes Care, 35
-
N. Dawson, M. Levings (2017)
Antigen-specific regulatory T cells: are police CARs the answer?Translational research : the journal of laboratory and clinical medicine, 187
-
J. Bluestone, J. Buckner, M. Fitch, S. Gitelman, Shipra Gupta, M. Hellerstein, K. Herold, A. Lares, Michael Lee, Kelvin Li, Weihong Liu, S. Long, Lisa Masiello, V. Nguyen, A. Putnam, M. Rieck, P. Sayre, Q. Tang (2015)
Type 1 diabetes immunotherapy using polyclonal regulatory T cellsScience Translational Medicine, 7
-
I. Rosado-Sánchez, M. Levings (2020)
Building a CAR-Treg: Going from the basic to the luxury model.Cellular immunology, 358
-
S. Chandran, Q. Tang, M. Sarwal, Zoltan Laszik, A. Putnam, Karim Lee, J. Leung, Vinh Nguyen, T. Sigdel, Erica Tavares, Joshua Yang, M. Hellerstein, Mark Fitch, J. Bluestone, Flavio Vincenti (2017)
Polyclonal Regulatory T Cell Therapy for Control of Inflammation in Kidney TransplantsAmerican Journal of Transplantation, 17
-
S. Todo, K. Yamashita, R. Goto, M. Zaitsu, A. Nagatsu, T. Oura, Masaaki Watanabe, T. Aoyagi, Tomomi Suzuki, T. Shimamura, T. Kamiyama, N. Sato, J. Sugita, K. Hatanaka, H. Bashuda, S. Habu, A. Demetris, K. Okumura (2016)
A pilot study of operational tolerance with a regulatory T‐cell‐based cell therapy in living donor liver transplantationHepatology, 64
-
C. Bennett, J. Christie, F. Ramsdell, M. Brunkow, P. Ferguson, L. Whitesell, T. Kelly, F. Saulsbury, P. Chance, H. Ochs (2001)
The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3Nature Genetics, 27
- Publisher
- Wiley
- Copyright
- © 2022 AABB
- ISSN
- 0041-1132
- eISSN
- 1537-2995
- DOI
- 10.1111/trf.16797
- Publisher site
- See Article on Publisher Site
Abstract
Journal
Transfusion – Wiley
Published: Apr 1, 2022